| Quantity: | |
|---|---|
This product contains live Mycoplasma bovis Strain HB150. The live bacterial count is no less than 1.0×10⁸ CFU per dose. Each cattle dose contains live Mycoplasma bovis Strain HB150, with a viable bacterial count of no less than 1.0×10⁸ CFU per dose.
Milky white or slightly yellow porous sponge cake readily detachable from the inne wall and rapidly soluble after adding sterile normal saline. Milky white or slightly yellow porous sponge cake, readily detachable from the inner wall of the vial; dissolves completely and rapidly after reconstitution with sterile normal saline diluent.
For the prevention of respiratory diseases caused by Mycoplasma bovis infection in cattle. Protective immunity is established 28 days after vaccination and lasts for 8 months.
For nasal drop administration only. Suitable for healthy cattle aged 1 month and above. Reconstitute the vaccine with sterile normal saline diluent as specified on the vial label. Administer 2.0 mL (containing 1 cattle dose) per animal.
1dose/vial;2 doses/vial;5 doses/vial;10 doses/vial;
Store at ≤ -20 °C. Shelf life: 18 months from the date of manufacture.
For use only under veterinary supervision.
Exclusive HB150 strain for targeted bovine respiratory disease prevention: Adopts exclusive high-quality bovine mycoplasma HB150 attenuated strain with mild virulence and stable performance. It accurately prevents bovine mycoplasma respiratory diseases and solves typical problems such as cough, asthma and slow growth in cattle.
Ultra-high viable bacteria content for strong and stable immunity: Each dose contains viable bacteria ≥1.0×10CFU. The ultra-high active bacteria content efficiently activates bovine immune function, builds a stable respiratory mucosal barrier, and provides reliable long-term protection against wild mycoplasma infection.
Long immune duration protects whole growth cycle: Effective immunity is stably generated 28 days after vaccination, with an immune duration of up to 8 months. It covers the key growth stages of cattle, reduces repeated vaccination and cuts daily respiratory disease prevention costs.
Non-invasive nasal vaccination with ultra-low stress: Non-invasive deep nasal dropping causes minimal stress. Transient slight temperature rise in individual cattle is a normal reversible stress reaction, with no impact on feeding and growth performance.
Targeted mucosal immunity blocks wild virus colonization: It targets the respiratory mucosal immune system and builds a defense barrier at the infection entrance to block wild mycoplasma colonization and diffusion, providing more targeted prevention for respiratory diseases than conventional injection vaccination.
High-quality freeze-dried formulation for efficient operation:The milky white or light yellow loose mass dissolves rapidly and completely after dilution without caking or residue, ensuring high uniformity and efficient batch vaccination for large-scale cattle farms.
Long shelf life and low storage loss: Stored below -20℃ away from light with an 18-month ultra-long validity period. It features low vaccine loss and flexible inventory turnover, suitable for long-term daily reserve of cattle farms.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is a live bovine mycoplasma vaccine (Strain HB150), a non-prescription veterinary drug, specially used to prevent bovine respiratory diseases caused by Mycoplasma bovis infection.
Q: What is the viable bacteria standard and core advantages?
A: Each dose contains viable Mycoplasma bovis HB150 strain ≥1.0×10CFU. With ultra-high viable bacteria content, targeted mucosal immunity, low stress and 8-month long protection, it effectively reduces the recurrence rate of bovine respiratory mycoplasma diseases.
Q: What are the applicable cattle, vaccination method and dosage?
A: Applicable to healthy cattle over 1 month old via deep nasal dropping. Dilute with sterile normal saline and vaccinate 2.0ml per cattle with non-invasive and simple operation.
Q: What are the immune onset time and protection duration?
A: Effective protective immunity is stably generated 28 days after standard vaccination, with an immune duration of up to 8 months, providing long-term protection against mycoplasma respiratory diseases and stabilizing cattle growth performance.
Q: What are the storage requirements and time limit for diluted vaccine?
A: Place the diluted vaccine in a cool and dark environment and use it up completely within 2 hours. Exceeding the time limit will reduce viable bacteria activity and lead to insufficient immune efficacy.
